{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:16:56Z","timestamp":1790083016929,"version":"4.0.1"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018890","name":"Dutch CardioVascular Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pharmthera.2023.108389","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T17:38:24Z","timestamp":1679333904000},"page":"108389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension"],"prefix":"10.1016","volume":"244","author":[{"given":"F.T.","family":"Bekedam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Goumans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Bogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lluci\u00e0-Valldeperas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108389_bb0005","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1172\/JCI95945","article-title":"The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction","volume":"128","author":"Abraham","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0010","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/s41598-017-03625-9","article-title":"Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy","volume":"7","author":"Abraityte","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00109-017-1529-1","article-title":"Wnt5a is elevated in heart failure and affects cardiac fibroblast function","volume":"95","author":"Abraityte","year":"2017","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0020","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/MCB.00199-15","article-title":"Genetic analysis of connective tissue growth factor as an effector of transforming growth factor \u03b2 signaling and cardiac remodeling","volume":"35","author":"Accornero","year":"2015","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.5966\/sctm.2015-0241","article-title":"Age-dependent effect of pediatric cardiac progenitor cells after juvenile heart failure","volume":"5","author":"Agarwal","year":"2016","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/1440-1681.12579","article-title":"Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease","volume":"43","author":"Ajith","year":"2016","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"129","key":"10.1016\/j.pharmthera.2023.108389_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1152\/japplphysiol.00148.2020","article-title":"Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension","volume":"1985","author":"Akazawa","year":"2020","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mri.2021.03.011","article-title":"Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis","volume":"79","author":"Alabed","year":"2021","journal-title":"Magnetic Resonance Imaging"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1043-2760(01)00498-2","article-title":"Receptor signaling and structure: insights from serotonin-1 receptors","volume":"12","author":"Albert","year":"2001","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation","volume":"115","author":"Ali","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0060","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.202110-2274OC","article-title":"Macrophage-NLRP3 activation promotes right ventricle failure in pulmonary arterial hypertension","volume":"206","author":"Al-Qazazi","year":"2022","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91-92","author":"AlQudah","year":"2020","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106151","article-title":"1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis","volume":"180","author":"Alves-Silva","year":"2022","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0075","doi-asserted-by":"crossref","first-page":"H1708","DOI":"10.1152\/ajpheart.00746.2012","article-title":"Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension","volume":"304","author":"Alzoubi","year":"2013","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019848659","article-title":"Pressure overload induced right ventricular remodeling is not attenuated by the anti-fibrotic agent pirfenidone","volume":"9","author":"Andersen","year":"2019","journal-title":"Pulm Circ"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.118.035326","article-title":"Right ventricular fibrosis","volume":"139","author":"Andersen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/aja.1000770303","article-title":"A determination of the diameters of ventricular myocardial fibers in man and other mammals","volume":"77","author":"Ashley","year":"1945","journal-title":"American Journal of Anatomy"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109869","article-title":"Diverse origins and activation of fibroblasts in cardiac fibrosis","volume":"78","author":"Aujla","year":"2021","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0100","doi-asserted-by":"crossref","first-page":"H1128","DOI":"10.1152\/ajpheart.00482.2012","article-title":"Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing","volume":"303","author":"Baicu","year":"2012","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/FJC.0b013e3182116e39","article-title":"Fibroblasts and myofibroblasts: what are we talking about?","volume":"57","author":"Baum","year":"2011","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/hrt.2007.118638","article-title":"Pulmonary embolism causes endomyocarditis in the human heart","volume":"94","author":"Begieneman","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00210-015-1205-3","article-title":"Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension","volume":"389","author":"Behringer","year":"2016","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","article-title":"c-kit+ cells minimally contribute cardiomyocytes to the heart","volume":"509","author":"van Berlo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12890-018-0604-x","article-title":"Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension","volume":"18","author":"Boehm","year":"2018","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1165\/rcmb.2018-0069OC","article-title":"Nitric oxide synthase 2 induction promotes right ventricular fibrosis","volume":"60","author":"Boehm","year":"2019","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1165\/rcmb.2020-0528OC","article-title":"Improving right ventricular function by increasing BMP signaling with FK506","volume":"65","author":"Boehm","year":"2021","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0140","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/cvr\/cvz310","article-title":"Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of pulmonary artery de-banding","volume":"116","author":"Boehm","year":"2020","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0145","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201007-1106OC","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0150","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.109.883843","article-title":"Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure","volume":"120","author":"Bogaard","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0155","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/rccm.201003-0335OC","article-title":"Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats","volume":"182","author":"Bogaard","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0160","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/eurjhf\/hfs094","article-title":"Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle","volume":"14","author":"Borgdorff","year":"2012","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0165","doi-asserted-by":"crossref","first-page":"H361","DOI":"10.1152\/ajpheart.00843.2013","article-title":"Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload","volume":"307","author":"Borgdorff","year":"2014","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0170","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.115.020696","article-title":"Bone morphogenetic protein receptor type 2 mutation in pulmonary arterial hypertension: A view on the right ventricle","volume":"133","author":"van der Bruggen","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1164\/rccm.201703-0502OC","article-title":"ASK1 inhibition halts disease progression in preclinical models of pulmonary arterial hypertension","volume":"197","author":"Budas","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00059-002-2354-y","article-title":"Cardiac fibrosis as a cause of diastolic dysfunction","volume":"27","author":"Burlew","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0190","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1152\/physrev.1954.34.4.619","article-title":"Relation of structure to function of the tissues of the wall of blood vessels","volume":"34","author":"Burton","year":"1954","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature06969","article-title":"A myocardial lineage derives from Tbx18 epicardial cells","volume":"454","author":"Cai","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0200","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308365","article-title":"Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension","volume":"102","author":"Calvier","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/13993003.00090-2016","article-title":"Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study","volume":"48","author":"van Campen","year":"2016","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100933","article-title":"SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis","volume":"36","author":"Cardoso","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yjmcc.2015.11.010","article-title":"Integrins and integrin-related proteins in cardiac fibrosis","volume":"93","author":"Chen","year":"2016","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2020.01.015","article-title":"The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension","volume":"524","author":"Chowdhury","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0225","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.005819","article-title":"Treatment of pulmonary hypertension with angiotensin II receptor blocker and neprilysin inhibitor sacubitril\/valsartan","volume":"12","author":"Clements","year":"2019","journal-title":"Circulation. Heart Failure"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0230","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.00087.2018","article-title":"Elastin, arterial mechanics, and cardiovascular disease","volume":"315","author":"Cocciolone","year":"2018","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0235","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmcc.2001.1381","article-title":"beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase","volume":"33","author":"Colombo","year":"2001","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-cellbio-100109-104126","article-title":"Transmembrane signaling proteoglycans","volume":"26","author":"Couchman","year":"2010","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0245","doi-asserted-by":"crossref","first-page":"H1109","DOI":"10.1152\/ajpheart.00153.2017","article-title":"\u03b1(1A)-Subtype adrenergic agonist therapy for the failing right ventricle","volume":"313","author":"Cowley","year":"2017","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0250","doi-asserted-by":"crossref","first-page":"H224","DOI":"10.1152\/ajpheart.00507.2018","article-title":"Reversal of right ventricular failure by chronic \u03b1(1A)-subtype adrenergic agonist therapy","volume":"316","author":"Cowley","year":"2019","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0255","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1164\/rccm.201809-1737OC","article-title":"Disconnect between fibrotic response and right ventricular dysfunction","volume":"199","author":"Crnkovic","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0260","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1113\/jphysiol.2012.235382","article-title":"Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential","volume":"591","author":"Dawson","year":"2013","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0265","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0146-2806(91)90009-Y","article-title":"The right ventricle: anatomy, physiology, and clinical importance","volume":"16","author":"Dell\u2019Italia","year":"1991","journal-title":"Current Problems in Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0270","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fphys.2018.01056","article-title":"Inflammation in right ventricular failure: Does it matter?","volume":"9","author":"Dewachter","year":"2018","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0275","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/1354750X.2014.918654","article-title":"Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6","volume":"19","author":"Dolenc","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0280","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2018.07.130","article-title":"CTGF\/CCN2 is an autocrine regulator of cardiac fibrosis","volume":"121","author":"Dorn","year":"2018","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810072","article-title":"WNT\/\u03b2-catenin signaling promotes TGF-\u03b2-mediated activation of human cardiac fibroblasts by enhancing IL-11 production","volume":"22","author":"Dzia\u0142o","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.582407","article-title":"Noncanonical WNT activation in human right ventricular heart failure","volume":"7","author":"Edwards","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yjmcc.2015.12.019","article-title":"Epicardium-derived fibroblasts in heart development and disease","volume":"91","author":"Fang","year":"2016","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0300","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-011-0804-9","article-title":"Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle\u2019s cycle","volume":"90","author":"Fang","year":"2012","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0305","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95240","article-title":"Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial","volume":"2","author":"Farha","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0310","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00380-015-0691-z","article-title":"Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension","volume":"31","author":"Fenster","year":"2016","journal-title":"Heart and Vessels"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0315","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10557-020-07115-5","article-title":"BK(Ca) channel activation attenuates the pathophysiological progression of monocrotaline-induced pulmonary arterial hypertension in wistar rats","volume":"35","author":"Ferraz","year":"2021","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0320","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2015.09.015","article-title":"CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload","volume":"88","author":"Fontes","year":"2015","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0325","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cvr\/cvx146","article-title":"Fibroblasts and the extracellular matrix in right ventricular disease","volume":"113","author":"Frangogiannis","year":"2017","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0330","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(00)00158-9","article-title":"Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb)","volume":"48","author":"Frangogiannis","year":"2000","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1532-429X-14-11","article-title":"Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension","volume":"14","author":"Freed","year":"2012","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0345","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0350","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fphys.2020.00416","article-title":"Cardiac fibrosis and cardiac fibroblast lineage-tracing: recent advances","volume":"11","author":"Fu","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0355","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/ars.2019.7753","article-title":"Galectin-3: A harbinger of reactive oxygen species, fibrosis, and inflammation in pulmonary arterial hypertension","volume":"31","author":"Fulton","year":"2019","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0360","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/FJC.0000000000000815","article-title":"Ursolic acid improves monocrotaline-induced right ventricular remodeling by regulating metabolism","volume":"75","author":"Gao","year":"2020","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0365","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: Mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0370","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1183\/09031936.00188013","article-title":"Iloprost reverses established fibrosis in experimental right ventricular failure","volume":"45","author":"Gomez-Arroyo","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0375","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0380","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/icvts\/ivx025","article-title":"Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension\u2020","volume":"24","author":"Gorter","year":"2017","journal-title":"Interactive Cardiovascular and Thoracic Surgery"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0385","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.ijcard.2013.01.165","article-title":"CCN2\/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload","volume":"168","author":"Gravning","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0390","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0395","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0300-8932(10)70012-9","article-title":"The right ventricle and pulmonary circulation: Basic concepts","volume":"63","author":"Greyson","year":"2010","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0400","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/hr.2013.129","article-title":"Inhibition of the Ca(2+)-sensing receptor rescues pulmonary hypertension in rats and mice","volume":"37","author":"Guo","year":"2014","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0405","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijcard.2009.04.019","article-title":"Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension","volume":"144","author":"von Haehling","year":"2010","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000080338","article-title":"Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts","volume":"14","author":"Hafizi","year":"2004","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0415","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0608799103","article-title":"Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice","volume":"103","author":"Haudek","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0420","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jash.2017.03.008","article-title":"Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4","volume":"11","author":"He","year":"2017","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0425","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2143\/AC.60.1.2005044","article-title":"Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy","volume":"60","author":"He","year":"2005","journal-title":"Acta Cardiologica"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0430","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02638-2017","article-title":"A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0435","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00428-004-1177-z","article-title":"Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies","volume":"446","author":"Herpel","year":"2005","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6050053","article-title":"The soft- and hard-heartedness of cardiac fibroblasts: Mechanotransduction signaling pathways in fibrosis of the heart","volume":"6","author":"Herum","year":"2017","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2012.11.006","article-title":"Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress","volume":"54","author":"Herum","year":"2013","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0450","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/cvr\/cvaa186","article-title":"The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease","volume":"117","author":"Hiram","year":"2021","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0455","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.bioeng.7.060804.100453","article-title":"Structure and mechanics of healing myocardial infarcts","volume":"7","author":"Holmes","year":"2005","journal-title":"Annual Review of Biomedical Engineering"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0460","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/FJC.0000000000000446","article-title":"Nitrite prevents right ventricular failure and remodeling induced by pulmonary artery banding","volume":"69","author":"Hu","year":"2017","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0465","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0470","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.715986","article-title":"Selective myeloid depletion of galectin-3 offers protection against acute and chronic lung injury","volume":"12","author":"Humphries","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0480","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1165\/rcmb.2019-0317OC","article-title":"Heart rate reduction improves right ventricular function and fibrosis in pulmonary hypertension","volume":"63","author":"Ishii","year":"2020","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2023.108389_bb0485","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1097\/00005344-199506263-00126","article-title":"Influence of pulmonary blood pressure and flow on endothelin-1 production in humans","volume":"26","author":"Ishikawa","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0490","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0379-0738(03)00138-5","article-title":"Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages","volume":"134","author":"Iwadate","year":"2003","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0495","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/438403","article-title":"5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure","volume":"2015","author":"Janssen","year":"2015","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020828","article-title":"ACE2 improves right ventricular function in a pressure overload model","volume":"6","author":"Johnson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0505","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1074\/jbc.M113.546812","article-title":"Antifibrotic effects of noscapine through activation of prostaglandin E2 receptors and protein kinase A","volume":"289","author":"Kach","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0510","doi-asserted-by":"crossref","first-page":"H853","DOI":"10.1152\/ajpheart.00321.2019","article-title":"Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"318","author":"Kang","year":"2020","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0515","doi-asserted-by":"crossref","first-page":"32116","DOI":"10.1074\/jbc.M204895200","article-title":"Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases","volume":"277","author":"Kim","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0520","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/dbio.2000.0106","article-title":"Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo","volume":"230","author":"Kisanuki","year":"2001","journal-title":"Developmental Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0525","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1165\/rcmb.2016-0374OC","article-title":"p38 MAPK inhibition improves heart function in pressure-loaded right ventricular hypertrophy","volume":"57","author":"Kojonazarov","year":"2017","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0530","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.ijcard.2012.06.129","article-title":"Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling","volume":"167","author":"Kojonazarov","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0535","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0540","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/ATVBAHA.120.315731","article-title":"Identification of celastrol as a novel therapeutic agent for pulmonary arterial hypertension and right ventricular failure through suppression of Bsg (Basigin)\/CyPA (Cyclophilin A)","volume":"41","author":"Kurosawa","year":"2021","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071716","article-title":"Cardiac fibrosis and fibroblasts","volume":"10","author":"Kurose","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2016.04.001","article-title":"Tensile mechanical properties of collagen type I and its enzymatic crosslinks","volume":"214-215","author":"Kwansa","year":"2016","journal-title":"Biophysical Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0555","doi-asserted-by":"crossref","first-page":"L375","DOI":"10.1152\/ajplung.00132.2016","article-title":"17\u03b2-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension","volume":"311","author":"Lahm","year":"2016","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0560","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0565","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0303","article-title":"PPAR\u03b3 agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation","volume":"10","author":"Legchenko","year":"2018","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0570","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0575","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21037\/cdt-21-360","article-title":"Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats","volume":"12","author":"Li","year":"2022","journal-title":"Cardiovascular Diagnosis and Therapy"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0580","article-title":"Dapagliflozin has no protective effect on experimental pulmonary arterial hypertension and pulmonary trunk banding rat models","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117624","article-title":"Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt\/\u03b2-catenin signaling pathway","volume":"252","author":"Li","year":"2020","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2022.07.006","article-title":"Integrins in cardiac fibrosis","volume":"172","author":"Li","year":"2022","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0595","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2019.10.006","article-title":"Acetaldehyde dehydrogenase 2 deficiency exacerbates cardiac fibrosis by promoting mobilization and homing of bone marrow fibroblast progenitor cells","volume":"137","author":"Li","year":"2019","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0600","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1172\/JCI39942","article-title":"Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts","volume":"120","author":"Liao","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/cvr\/cvz016","article-title":"Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of \u03b2-catenin","volume":"116","author":"Lin","year":"2020","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0610","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0615","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0620","doi-asserted-by":"crossref","first-page":"H273","DOI":"10.1152\/ajpheart.00758.2013","article-title":"Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension","volume":"307","author":"Liu","year":"2014","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0625","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00210-017-1443-7","article-title":"Transient receptor potential vanilloid-3 (TRPV3) activation plays a central role in cardiac fibrosis induced by pressure overload in rats via TGF-\u03b2(1) pathway","volume":"391","author":"Liu","year":"2018","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0630","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCHEARTFAILURE.111.964494","article-title":"Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension","volume":"5","author":"de Man","year":"2012","journal-title":"Circulation. Heart Failure"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0635","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","article-title":"Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension","volume":"186","author":"de Man","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0640","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040770","article-title":"Cardiac fibrosis: Key role of integrins in cardiac homeostasis and remodeling","volume":"10","author":"Meagher","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0650","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12968-015-0209-y","article-title":"Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance","volume":"17","author":"Mehta","year":"2015","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0655","doi-asserted-by":"crossref","first-page":"H1139","DOI":"10.1152\/ajpheart.00881.2005","article-title":"IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways","volume":"292","author":"Mitchell","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0660","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","article-title":"Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis","volume":"136","author":"Molkentin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0665","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0670","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00109-015-1314-y","article-title":"Cardiac fibroblasts: from development to heart failure","volume":"93","author":"Moore-Morris","year":"2015","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0675","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"Murphy","year":"2015","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0680","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.kint.2017.02.013","article-title":"Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications","volume":"92","author":"Noh","year":"2017","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0685","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.lfs.2017.10.034","article-title":"Sustained \u03b2-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation","volume":"193","author":"Nuamnaichati","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0690","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00395-010-0100-9","article-title":"Active Wnt signaling in response to cardiac injury","volume":"105","author":"Oerlemans","year":"2010","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0695","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00109-015-1251-9","article-title":"Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension","volume":"93","author":"Okumura","year":"2015","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0700","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/CIRCULATIONAHA.120.047626","article-title":"Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension","volume":"142","author":"Omura","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0705","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13287-015-0044-y","article-title":"Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload","volume":"6","author":"Oommen","year":"2015","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0710","first-page":"2010","article-title":"Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension","author":"Overbeek","year":"2010","journal-title":"International Journal of Rheumatology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0715","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2016.11.131","article-title":"Detection of right ventricular myocardial fibrosis using quantitative CT attenuation of the right ventricular myocardium in the late phase on 320 slice CT in subjects with pulmonary hypertension","volume":"228","author":"Ozawa","year":"2017","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0720","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007058","article-title":"Transcriptomic analysis of right ventricular remodeling in two rat models of pulmonary hypertension: identification and validation of epithelial-to-mesenchymal transition in human right ventricular failure","volume":"14","author":"Park","year":"2021","journal-title":"Circulation. Heart Failure"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0725","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ehf2.12565","article-title":"Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension","volume":"7","author":"Patel","year":"2020","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0730","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.RES.0000047090.08299.D5","article-title":"Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis","volume":"91","author":"Peng","year":"2002","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0735","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1096\/fj.201801659R","article-title":"Therapeutic effect of pirfenidone in the sugen\/hypoxia rat model of severe pulmonary hypertension","volume":"33","author":"Poble","year":"2019","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0740","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","article-title":"Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension","volume":"304","author":"Preston","year":"2013","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.834179","article-title":"Proteomic and metabolomic analyses of right ventricular failure due to pulmonary arterial hypertension","volume":"9","author":"Qin","year":"2022","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101935","article-title":"Magnesium lithospermate B improves pulmonary artery banding induced right ventricular dysfunction by alleviating inflammation via p38MAPK pathway","volume":"63","author":"Qu","year":"2020","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0755","first-page":"3293584","article-title":"Effect of riociguat and sildenafil on right heart remodeling and function in pressure overload induced model of pulmonary arterial banding","volume":"2018","author":"Rai","year":"2018","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0760","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002636","article-title":"Right ventricular myocardial stiffness in experimental pulmonary arterial hypertension: Relative contribution of fibrosis and myofibril stiffness","volume":"9","author":"Rain","year":"2016","journal-title":"Circulation. Heart Failure"},{"issue":"2016\u20132025","key":"10.1016\/j.pharmthera.2023.108389_bb0765","article-title":"Right ventricular diastolic impairment in patients with pulmonary arterial hypertension","volume":"128","author":"Rain","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0770","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FJC.0000000000001015","article-title":"Quercetin, perillyl alcohol, and berberine ameliorate right ventricular disorders in experimental pulmonary arterial hypertension: Effects on miR-204, miR-27a, fibrotic, apoptotic, and inflammatory factors","volume":"77","author":"Rajabi","year":"2021","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0775","doi-asserted-by":"crossref","first-page":"H1038","DOI":"10.1152\/ajpheart.00097.2009","article-title":"Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure","volume":"298","author":"Redout","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0780","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ccd.1810350105","article-title":"The forgotten chamber: the importance of the right ventricle","volume":"35","author":"Rigolin","year":"1995","journal-title":"Catheterization and Cardiovascular Diagnosis"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0785","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019873548","article-title":"Bisoprolol therapy does not reduce right ventricular sympathetic activity in pulmonary arterial hypertension patients","volume":"10","author":"Rijnierse","year":"2020","journal-title":"Pulmonary Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0790","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2013.12.024","article-title":"The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?","volume":"118","author":"Rodr\u00edguez-Pascual","year":"2014","journal-title":"Life Sciences"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2023.108389_bb0795","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.fjc.0000166216.27544.22","article-title":"Transforming growth factor-beta induces endothelin-1 expression through activation of the Smad signaling pathway","volume":"44","author":"Rodr\u00edguez-Pascual","year":"2004","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0800","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvy186","article-title":"Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension","volume":"115","author":"Rol","year":"2019","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092585","article-title":"TGF-\u03b2 and BMPR2 signaling in PAH: Two black sheep in one family","volume":"19","author":"Rol","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0810","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00330-016-4585-y","article-title":"Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension","volume":"27","author":"Roller","year":"2017","journal-title":"European Radiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0815","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00004872-199816070-00018","article-title":"Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans","volume":"16","author":"Rossi","year":"1998","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0820","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circulation Research"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2023.108389_bb0825","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2016.08.022","article-title":"Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence","volume":"122","author":"Sandner","year":"2017","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0830","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jacc.2018.12.076","article-title":"Anatomy, function, and dysfunction of the right ventricle: JACC state-of-the-art review","volume":"73","author":"Sanz","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0835","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1096\/fj.201902815R","article-title":"Small proline-rich repeat 3 is a novel coordinator of PDGFR\u03b2 and integrin \u03b21 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts","volume":"34","author":"Saraswati","year":"2020","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0840","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/cvr\/cvu053","article-title":"Integrins \u03b1v\u03b25 and \u03b1v\u03b23 promote latent TGF-\u03b21 activation by human cardiac fibroblast contraction","volume":"102","author":"Sarrazy","year":"2014","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0845","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.1300725","article-title":"IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium","volume":"191","author":"Saxena","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.886553","article-title":"Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target","volume":"9","author":"Schimmel","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0855","doi-asserted-by":"crossref","first-page":"H1005","DOI":"10.1152\/ajpheart.00091.2018","article-title":"Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats","volume":"316","author":"Schmuck","year":"2019","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0860","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz Jel","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0865","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.119.13696","article-title":"Gal-3 (Galectin-3) and K<sub>Ca<\/sub>3.1 mediate heterogeneous cell coupling and myocardial fibrogenesis driven by &#x3b2;AR (&#x3b2;-Adrenoceptor) activation","volume":"75","author":"She","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0870","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1164\/rccm.201205-0880OC","article-title":"Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models","volume":"187","author":"Shenoy","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0875","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.81.5.664","article-title":"Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload","volume":"81","author":"Shioi","year":"1997","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0880","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.662870","article-title":"Acetazolamide improves right ventricular function and metabolic gene dysregulation in experimental pulmonary arterial hypertension","volume":"8","author":"Spyropoulos","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0890","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/cvr\/cvx159","article-title":"Role of cardiac inflammation in right ventricular failure","volume":"113","author":"Sun","year":"2017","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0895","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1080\/21655979.2022.2065953","article-title":"Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension","volume":"13","author":"Sun","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0900","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Current Heart Failure Reports"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0905","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac fibroblast diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0910","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphar.2017.00313","article-title":"Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis","volume":"8","author":"Tesch","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0915","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis","volume":"118","author":"Travers","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0920","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1183\/09031936.00156714","article-title":"Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension","volume":"45","author":"Trip","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0925","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142945","article-title":"\u03b17 Nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension","volume":"6","author":"Vang","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0930","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ejhf.495","article-title":"MicroRNAs in heart failure: From biomarker to target for therapy","volume":"18","author":"Vegter","year":"2016","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0935","doi-asserted-by":"crossref","first-page":"14414","DOI":"10.1074\/jbc.M809757200","article-title":"WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death","volume":"284","author":"Venkatachalam","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0940","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.734917","article-title":"An insight on multicentric signaling of angiotensin II in cardiovascular system: A recent update","volume":"12","author":"Verma","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0945","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1074\/jbc.M100754200","article-title":"Identification of novel TGF-beta \/Smad gene targets in dermal fibroblasts using a combined cDNA microarray\/promoter transactivation approach","volume":"276","author":"Verrecchia","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0950","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00125-016-4194-y","article-title":"The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects","volume":"60","author":"Vettor","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0955","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2011.08.109","article-title":"TNF-\u03b1 increases cardiac fibroblast lysyl oxidase expression through TGF-\u03b2 and PI3Kinase signaling pathways","volume":"413","author":"Voloshenyuk","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"112","key":"10.1016\/j.pharmthera.2023.108389_bb0960","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1152\/japplphysiol.01350.2011","article-title":"Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle","volume":"1985","author":"Waehre","year":"2012","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0965","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2741\/4405","article-title":"Phenylephrine promotes cardiac fibroblast proliferation through calcineurin-NFAT pathway","volume":"21","author":"Wang","year":"2016","journal-title":"Frontiers in Bioscience (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0970","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/labinvest.2016.65","article-title":"Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-\u03b21 signaling pathway","volume":"96","author":"Wang","year":"2016","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0975","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2741\/4214","article-title":"Wnt and the Wnt signaling pathway in bone development and disease","volume":"19","author":"Wang","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0980","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10554-018-1468-0","article-title":"17\u03b2-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study","volume":"35","author":"Wang","year":"2019","journal-title":"The International Journal of Cardiovascular Imaging"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0985","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","article-title":"Cardiac interstitium in health and disease: The fibrillar collagen network","volume":"13","author":"Weber","year":"1989","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0990","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb0995","doi-asserted-by":"crossref","first-page":"H1816","DOI":"10.1152\/ajpheart.00955.2015","article-title":"Mesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload","volume":"310","author":"Wehman","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1000","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lfs.2018.01.021","article-title":"Defining the molecular signatures of human right heart failure","volume":"196","author":"Williams","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1005","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1010","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-017-00840-w","article-title":"Loss of \u03b2-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice","volume":"8","author":"Xiang","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1015","article-title":"Tsantan sumtang restored right ventricular function in chronic hypoxia-induced pulmonary hypertension rats","volume":"11","author":"Yang","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/cvr\/cvy209","article-title":"Inhibition of TLR9-NF-\u03baB-mediated sterile inflammation improves pressure overload-induced right ventricular dysfunction in rats","volume":"115","author":"Yoshida","year":"2019","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12964-020-00555-4","article-title":"TGF-\u03b2 and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus","volume":"18","author":"Yousefi","year":"2020","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1030","first-page":"11302","article-title":"Sevoflurane prevents pulmonary vascular remodeling and right ventricular dysfunction in pulmonary arterial hypertension in rats","volume":"13","author":"Zhai","year":"2021","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1035","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/CIRCULATIONAHA.121.055417","article-title":"Seamless genetic recording of transiently activated mesenchymal gene expression in endothelial cells during cardiac fibrosis","volume":"144","author":"Zhang","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1040","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00424-015-1694-4","article-title":"The role of KCa3.1 channels in cardiac fibrosis induced by pressure overload in rats","volume":"467","author":"Zhao","year":"2015","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1045","doi-asserted-by":"crossref","first-page":"H1719","DOI":"10.1152\/ajpheart.00130.2013","article-title":"Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts","volume":"304","author":"Zhao","year":"2013","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108389_bb1055","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41419-021-04152-2","article-title":"Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload","volume":"12","author":"Zou","year":"2021","journal-title":"Cell Death & Disease"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:32:44Z","timestamp":1759012364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":211,"alternative-id":["S0163725823000530"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108389","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108389"}}